0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-376.19%PremiumJan 17, 2025Expiry Date3.95Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.27Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Century Therapeutics Stock Discussion
Clear Street Launches Healthcare & Biotechnology Equity Research
Tuesday, 17th December at 2:00 pm
Comprehensive Biotechnology sector market analysis and investment insights complement recently launched Disruptive Technology and Energy Transition franchises
Clear Street, ("Clear Street", "the Company") a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the expansion of its recently launched equity resear...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$